Current human data can be categorized into three distinct areas: safety and tolerability, metabolic outcomes, and signals for disease modification
GLP-1 agonists act on your brain to dial down those hunger signals, making it easier to just say Im not hungry
It felt more like therapy than a medical intake
These include but are likely not limited to chronic hyperglycemia, hypertension, dyslipidemia, obesity, insulin resistance, sodium retention, neurohormonal activation and low-grade inflammation, all related to the metabolic syndrome [9, 10]
This is not eat reasonably and go for walks territory
Currently, oral semaglutide is prescribed in 3 mg, 7 mg, and 14 mg formulations